X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-22 | PMVP | Orbimed Advisors LLC | 10% | S - Sale | $2.23 | -87,786 | 6,475,291 | -1% | -$195,763 | ||||||
2023-09-15 | PMVP | Jalota Deepika | Chief Development Officer | S - Sale | $6.62 | -4,104 | 29,946 | -12% | -$27,168 | ||||||
2023-09-15 | PMVP | Alland Leila | Chief Medical Officer | S - Sale | $6.62 | -6,291 | 45,909 | -12% | -$41,646 | ||||||
2022-05-26 | PMVP | Orbimed Advisors LLC | 10% | S - Sale | $15.93 | -26,253 | 6,563,077 | 0% | -$418,210 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |